Upgrade to SI Premium - Free Trial

StoneX Reiterates Buy Rating on Prenetics (PRE)

September 8, 2026 9:33 AM
StoneX analyst Bill Sutherland reiterated a Buy rating and $40.00 price target on Prenetics (NASDAQ: PRE).The analyst commented, "We reiterate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments